Aegon's Q1 2016 Results Impacted by Volatile Markets
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Mizuho Securities Remains Sidelined on Allergan (AGN) following 1Q Earnings; PT to $232
May 13, 2016 6:52 AM EDTMizuho Securities maintained a Neutral rating on Allergen (NYSE: AGN), and cut the price target to $232.00 (from $250.00), following the company's 1Q earnings report. AGN reported $3.8B in revenues and EPS of $3.04 vs. consensus estimates $3.95B and $3.00. Management reiterated its FY16 revenue guidance of... More
